Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus (EPOinDR)

This study has been terminated.
(Patient recruitment was not sufficient to achieve the needed patient numbers.)
Sponsor:
Collaborator:
Amgen
Information provided by:
Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT00704652
First received: June 23, 2008
Last updated: September 17, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)